Reaction

High Density Lipoprotein Decreased reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 3,296 reports · 96 co-occurring drugs

As of the last recalculation, High Density Lipoprotein Decreased appears in 3,296 FAERS reports alongside 96 co-occurring drug terms. The strongest observed disproportionality signal is INCLISIRAN (PRR 40.0).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Inclisiran	50	40.0	40.2
Fenofibrate	160	29.9	30.0
Rosuvastatin	548	20.1	20.1
Niacin	36	19.8	19.8
Ezetimibe	177	15.7	15.7
Umeclidinium	21	14.9	14.9
Gemfibrozil	35	14.7	14.7
Methoxy Polyethylene Glycol-Epoetin Beta	23	13.2	13.3
Alirocumab	46	11.7	11.8
Atorvastatin Calcium	397	11.4	11.4
Icosapent Ethyl	15	11.2	11.2
Olanzapine Pamoate	68	10.7	10.7
Ezetimibe And Simvastatin	22	9.2	9.2
Metformin Hcl	68	7.9	7.9
Atorvastatin Calcium, Film Coated	84	7.7	7.7
Clozapine	145	7.6	7.6
Pioglitazone	51	7.5	7.6
Basiliximab	14	7.5	7.6
Sevelamer Carbonate	13	7.2	7.2
Glyburide	27	7.1	7.1
Olanzapine	113	6.8	6.8
Rosuvastatin Calcium	30	6.8	6.8
Indapamide	19	6.7	6.7
Testosterone	24	6.5	6.5
Fish Oil	91	6.5	6.5
Isotretinoin	50	6.5	6.5
Nitroglycerin	54	6.4	6.5
Eplerenone	13	6.4	6.4
Candesartan	35	6.3	6.3
Pitavastatin Calcium	10	6.2	6.2
Sirolimus	13	6.1	6.1
Sodium Bicarbonate	22	6.0	6.0
Sodium Bicarbonate Injection,	22	6.0	6.0
Abacavir Sulfate	9	5.8	5.9
Amlodipine Besylate And Valsartan	10	5.7	5.7
Lisinopril And Hydrochlorothiazide Tablets	7	5.6	5.6
Quinapril Hydrochloride	7	5.6	5.6
Lisinopril And Hydrochlorothiazide	9	5.6	5.6
Aripiprazole Oral	36	5.5	5.6
Aripiprazole Orally Disintegrating	36	5.5	5.6
Heparin Sodium	12	5.5	5.5
Atenolol	113	5.5	5.5
Amlodipine Besylate And Benazepril Hydrochloride	8	5.5	5.5
Ranolazine	9	5.5	5.5
Paliperidone	20	5.4	5.4
Dofetilide	9	5.4	5.4
Ticagrelor	27	5.4	5.4
Aspirin 325 Mg	391	5.3	5.3
Aspirin 81 Mg	391	5.3	5.3
Calcium Gluconate	10	5.3	5.3
Aspirin	400	5.2	5.2
Torsemide	27	5.2	5.2
Psyllium Husk	8	5.1	5.1
Metoprolol Succinate	69	5.1	5.1
Evolocumab	127	5.1	5.1
Candesartan Cilexetil	21	5.1	5.1
Febuxostat Tablets 40 Mg	8	5.0	5.0
Febuxostat Tablets 80 Mg	8	5.0	5.0
Simvastatin	188	5.0	5.0
Testosterone Cypionate	7	5.0	5.0
Ganciclovir	8	4.9	4.9
Metoprolol Succinate Er Tablets	48	4.9	4.9
Nevirapine	7	4.9	4.9
Isosorbide Mononitrate	16	4.9	4.9
Ziprasidone Mesylate	11	4.9	4.9
Methimazole	6	4.8	4.8
Ganciclovir Sodium	8	4.8	4.8
Glipizide	45	4.7	4.7
Insulin	41	4.7	4.7
Valsartan	73	4.5	4.5
Trazodone Hydrochloride	11	4.5	4.5
Felodipine Extended-Release Tablets	8	4.4	4.4
Felodipine	8	4.4	4.4
Somatropin	51	4.4	4.4
Asfotase Alfa	7	4.4	4.4
Anastrozole	25	4.3	4.3
Zidovudine	9	4.3	4.3
Divalproex Sodium	31	4.2	4.2
Aripiprazole	79	4.1	4.2
Ziprasidone	11	4.0	4.0
Tolvaptan	9	3.9	3.9
Clopidogrel	119	3.9	3.9
Metoroprolol Tartrate	40	3.9	3.9
Timolol Maleate	6	3.8	3.8
Dapagliflozin	18	3.6	3.6
Risperidone	63	3.0	3.0
Exenatide	23	2.8	2.8
Prasugrel Hydrochloride	4	2.5	2.5
Asenapine Maleate	3	2.2	2.2
Tafamidis	4	2.1	2.1
Fingolimod Hcl	29	2.1	2.1
Sacubitril And Valsartan	37	2.0	2.0
Varenicline Tartrate	25	2.0	2.0
Medroxyprogesterone Acetate	15	1.9	1.9
Orlistat	5	1.2	1.2
Salicylic Acid	3	0.4	0.4

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.